GalNAcα(1-3)GalNAcβ(1-3)Galα(1-4)Galβ(1-4)Glcβ MP Glycoside
BR
- Product Code: 103793
Alias:
Forssman Pentaose MP Glycoside; Forssman Pentaose MP Glycoside
CAS:
1858224-10-8
| Molecular Weight: | 1016.95 g./mol | Molecular Formula: | C₄₁H₆₄N₂O₂₇ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
GalNAcα(1-3)GalNAcβ(1-3)Galα(1-4)Galβ(1-4)Glcβ MP Glycoside is primarily used in glycobiology research to study carbohydrate-protein interactions. It serves as a synthetic oligosaccharide model to understand the binding mechanisms of lectins, enzymes, and other glycan-recognizing proteins. This compound is valuable in exploring the role of specific glycan structures in cellular communication, immune responses, and pathogen recognition. Additionally, it is utilized in the development of glycoconjugate vaccines and therapeutics, where precise glycan structures are essential for eliciting targeted immune responses. Its application extends to diagnostic tools for detecting glycan-related biomarkers in diseases such as cancer and infectious disorders.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | Ft102,354.03 |
+
-
|
GalNAcα(1-3)GalNAcβ(1-3)Galα(1-4)Galβ(1-4)Glcβ MP Glycoside
GalNAcα(1-3)GalNAcβ(1-3)Galα(1-4)Galβ(1-4)Glcβ MP Glycoside is primarily used in glycobiology research to study carbohydrate-protein interactions. It serves as a synthetic oligosaccharide model to understand the binding mechanisms of lectins, enzymes, and other glycan-recognizing proteins. This compound is valuable in exploring the role of specific glycan structures in cellular communication, immune responses, and pathogen recognition. Additionally, it is utilized in the development of glycoconjugate vaccines and therapeutics, where precise glycan structures are essential for eliciting targeted immune responses. Its application extends to diagnostic tools for detecting glycan-related biomarkers in diseases such as cancer and infectious disorders.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :